vs
GRID DYNAMICS HOLDINGS, INC.（GDYN）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是GRID DYNAMICS HOLDINGS, INC.的1.2倍（$127.1M vs $104.1M），再鼎医药同比增速更快（17.1% vs 3.7%），过去两年再鼎医药的营收复合增速更高（20.8% vs 12.0%）
Escape Dynamics Inc.是一家总部位于科罗拉多州的科技企业，活跃于2010年至2015年，核心业务方向是研发可单级入轨、依靠电磁驱动的可重复使用航天飞机，并推动该项目实现商业化落地。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
GDYN vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.2倍
$104.1M
营收增速更快
ZLAB
高出13.4%
3.7%
两年增速更快
ZLAB
近两年复合增速
12.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.1M | $127.1M |
| 净利润 | $-1.5M | — |
| 毛利率 | 34.8% | 51.0% |
| 营业利润率 | 61.7% | -54.6% |
| 净利率 | -1.4% | — |
| 营收同比 | 3.7% | 17.1% |
| 净利润同比 | -150.6% | — |
| 每股收益（稀释后） | $-0.02 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GDYNZLAB
| Q1 26 | $104.1M | — | ||
| Q4 25 | $106.2M | $127.1M | ||
| Q3 25 | $104.2M | $115.4M | ||
| Q2 25 | $101.1M | $109.1M | ||
| Q1 25 | $100.4M | $105.7M | ||
| Q4 24 | $100.3M | $108.5M | ||
| Q3 24 | $87.4M | $101.8M | ||
| Q2 24 | $83.0M | $100.1M |
净利润GDYNZLAB
| Q1 26 | $-1.5M | — | ||
| Q4 25 | $306.0K | — | ||
| Q3 25 | $1.2M | $-36.0M | ||
| Q2 25 | $5.3M | $-40.7M | ||
| Q1 25 | $2.9M | $-48.4M | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $4.3M | $-41.7M | ||
| Q2 24 | $-817.0K | $-80.3M |
毛利率GDYNZLAB
| Q1 26 | 34.8% | — | ||
| Q4 25 | 34.0% | 51.0% | ||
| Q3 25 | 33.3% | 59.5% | ||
| Q2 25 | 34.1% | 60.6% | ||
| Q1 25 | 36.8% | 63.6% | ||
| Q4 24 | 36.9% | 61.5% | ||
| Q3 24 | 37.4% | 64.1% | ||
| Q2 24 | 35.6% | 64.9% |
营业利润率GDYNZLAB
| Q1 26 | 61.7% | — | ||
| Q4 25 | 0.5% | -54.6% | ||
| Q3 25 | -0.2% | -42.3% | ||
| Q2 25 | -0.1% | -50.3% | ||
| Q1 25 | -2.0% | -53.3% | ||
| Q4 24 | 1.3% | -62.6% | ||
| Q3 24 | 2.4% | -66.6% | ||
| Q2 24 | 0.0% | -76.0% |
净利率GDYNZLAB
| Q1 26 | -1.4% | — | ||
| Q4 25 | 0.3% | — | ||
| Q3 25 | 1.1% | -31.2% | ||
| Q2 25 | 5.2% | -37.3% | ||
| Q1 25 | 2.9% | -45.8% | ||
| Q4 24 | 4.5% | — | ||
| Q3 24 | 4.9% | -40.9% | ||
| Q2 24 | -1.0% | -80.2% |
每股收益（稀释后）GDYNZLAB
| Q1 26 | $-0.02 | — | ||
| Q4 25 | $0.01 | $-0.05 | ||
| Q3 25 | $0.01 | $-0.03 | ||
| Q2 25 | $0.06 | $-0.04 | ||
| Q1 25 | $0.03 | $-0.04 | ||
| Q4 24 | $0.06 | $-0.09 | ||
| Q3 24 | $0.05 | $-0.04 | ||
| Q2 24 | $-0.01 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $327.5M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $530.1M | $715.5M |
| 总资产 | $605.0M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GDYNZLAB
| Q1 26 | $327.5M | — | ||
| Q4 25 | $342.1M | $689.6M | ||
| Q3 25 | $338.6M | $717.2M | ||
| Q2 25 | $336.8M | $732.2M | ||
| Q1 25 | $325.5M | $757.3M | ||
| Q4 24 | $334.7M | $779.7M | ||
| Q3 24 | $231.3M | $616.1M | ||
| Q2 24 | $256.0M | $630.0M |
股东权益GDYNZLAB
| Q1 26 | $530.1M | — | ||
| Q4 25 | $542.1M | $715.5M | ||
| Q3 25 | $537.7M | $759.9M | ||
| Q2 25 | $532.2M | $791.7M | ||
| Q1 25 | $517.4M | $810.8M | ||
| Q4 24 | $517.8M | $840.9M | ||
| Q3 24 | $400.2M | $667.7M | ||
| Q2 24 | $388.4M | $704.2M |
总资产GDYNZLAB
| Q1 26 | $605.0M | — | ||
| Q4 25 | $612.9M | $1.2B | ||
| Q3 25 | $613.2M | $1.2B | ||
| Q2 25 | $608.9M | $1.2B | ||
| Q1 25 | $590.9M | $1.2B | ||
| Q4 24 | $592.2M | $1.2B | ||
| Q3 24 | $477.3M | $985.3M | ||
| Q2 24 | $443.6M | $987.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-26.7M |
| 自由现金流率自由现金流/营收 | — | -21.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流GDYNZLAB
| Q1 26 | — | — | ||
| Q4 25 | $9.9M | $-26.0M | ||
| Q3 25 | $7.0M | $-32.0M | ||
| Q2 25 | $14.4M | $-31.0M | ||
| Q1 25 | $9.4M | $-61.7M | ||
| Q4 24 | $7.1M | $-55.8M | ||
| Q3 24 | $9.2M | $-26.8M | ||
| Q2 24 | $10.7M | $-42.2M |
自由现金流GDYNZLAB
| Q1 26 | — | — | ||
| Q4 25 | $6.1M | $-26.7M | ||
| Q3 25 | $2.9M | $-35.0M | ||
| Q2 25 | $10.2M | $-33.9M | ||
| Q1 25 | $6.0M | $-63.2M | ||
| Q4 24 | $4.4M | $-58.4M | ||
| Q3 24 | $5.9M | $-28.2M | ||
| Q2 24 | $8.0M | $-42.9M |
自由现金流率GDYNZLAB
| Q1 26 | — | — | ||
| Q4 25 | 5.7% | -21.0% | ||
| Q3 25 | 2.8% | -30.4% | ||
| Q2 25 | 10.1% | -31.1% | ||
| Q1 25 | 6.0% | -59.9% | ||
| Q4 24 | 4.4% | -53.8% | ||
| Q3 24 | 6.8% | -27.7% | ||
| Q2 24 | 9.7% | -42.9% |
资本支出强度GDYNZLAB
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | 0.5% | ||
| Q3 25 | 3.9% | 2.6% | ||
| Q2 25 | 4.1% | 2.6% | ||
| Q1 25 | 3.3% | 1.5% | ||
| Q4 24 | 2.6% | 2.4% | ||
| Q3 24 | 3.7% | 1.3% | ||
| Q2 24 | 3.2% | 0.7% |
现金转化率GDYNZLAB
| Q1 26 | — | — | ||
| Q4 25 | 32.34× | — | ||
| Q3 25 | 5.92× | — | ||
| Q2 25 | 2.73× | — | ||
| Q1 25 | 3.21× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 2.15× | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GDYN
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
